BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21853343)

  • 21. The relevance of surgical margins in clinically early oral squamous cell carcinoma.
    Bajwa MS; Houghton D; Java K; Triantafyllou A; Khattak O; Bekiroglu F; Schache AG; Brown JS; McCaul JA; Rogers SN; Lowe D; McMahon J; Shaw RJ
    Oral Oncol; 2020 Nov; 110():104913. PubMed ID: 32711167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma.
    Yang CZ; Ma J; Zhu DW; Liu Y; Montgomery B; Wang LZ; Li J; Zhang ZY; Zhang CP; Zhong LP
    Ann Oncol; 2014 Jun; 25(6):1215-22. PubMed ID: 24669014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between the C-reactive protein/albumin ratio and prognosis in patients with oral squamous cell carcinoma.
    Yamagata K; Fukuzawa S; Ishibashi-Kanno N; Uchida F; Bukawa H
    Sci Rep; 2021 Mar; 11(1):5446. PubMed ID: 33686103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
    Jiang T; Xie P; Liu H
    J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The level and clinical significance of 5-hydroxymethylcytosine in oral squamous cell carcinoma: An immunohistochemical study in 95 patients.
    Wang Y; Hu H; Wang Q; Li Z; Zhu Y; Zhang W; Wang Y; Jiang H; Cheng J
    Pathol Res Pract; 2017 Aug; 213(8):969-974. PubMed ID: 28554766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
    Kang Y; Zhang Y; Sun Y
    Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Positive lymph node ratio is an important prognostic factor of oral squamous cell carcinoma].
    Yang S; Wang D; Wang X; Mao C
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2016 Mar; 51(3):133-6. PubMed ID: 26980649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemoglobin, C-reactive protein and ferritin in patients with oral carcinoma and their clinical significance - A prospective clinical study.
    Blatt S; Schön H; Sagheb K; Kämmerer PW; Al-Nawas B; Schiegnitz E
    J Craniomaxillofac Surg; 2018 Feb; 46(2):207-212. PubMed ID: 29287926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
    Lee CE; Vincent-Chong VK; Ramanathan A; Kallarakkal TG; Karen-Ng LP; Ghani WM; Rahman ZA; Ismail SM; Abraham MT; Tay KK; Mustafa WM; Cheong SC; Zain RB
    Int J Med Sci; 2015; 12(12):937-45. PubMed ID: 26664254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells.
    Grimm M; Schmitt S; Teriete P; Biegner T; Stenzl A; Hennenlotter J; Muhs HJ; Munz A; Nadtotschi T; König K; Sänger J; Feyen O; Hofmann H; Reinert S; Coy JF
    BMC Cancer; 2013 Dec; 13():569. PubMed ID: 24304513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype.
    Satgunaseelan L; Gupta R; Madore J; Chia N; Lum T; Palme CE; Boyer M; Scolyer RA; Clark JR
    Pathology; 2016 Oct; 48(6):574-80. PubMed ID: 27590194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased placenta growth factor mRNA level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
    Cheng SJ; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Chiang ML; Kuo MY
    J Formos Med Assoc; 2013 May; 112(5):253-8. PubMed ID: 23660220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulated LOX and increased collagen content associated with aggressive clinicopathological features and unfavorable outcome in oral squamous cell carcinoma.
    Yu M; Shen W; Shi X; Wang Q; Zhu L; Xu X; Yu J; Liu L
    J Cell Biochem; 2019 Sep; 120(9):14348-14359. PubMed ID: 31140650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
    Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH
    BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic effect of surgical treatment in elderly oral squamous cell carcinoma patients: A retrospective study.
    Zhi Y; Li S; Li Y; Ren W; Gao L; Zhi K
    Oral Oncol; 2024 Jul; 154():106849. PubMed ID: 38749112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.
    Kurihara-Shimomura M; Sasahira T; Nakamura H; Nakashima C; Kuniyasu H; Kirita T
    J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma.
    Lin LH; Lin JS; Yang CC; Cheng HW; Chang KW; Liu CJ
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
    Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
    World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of beta-2 adrenergic receptor in oral squamous cell carcinoma.
    Bravo-Calderón DM; Oliveira DT; Marana AN; Nonogaki S; Carvalho AL; Kowalski LP
    Cancer Biomark; 2011-2012; 10(1):51-9. PubMed ID: 22297552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.